Loading...
 
Back to the list
Mediterr J Rheumatol 2017;28(2):86-93
Article Links
Determining the presence of Peripheral Arterial Disease in patients with Rheumatoid Arthritis
Andrea C. Grech1,2, Alfred Gatt2, Andrew A. Borg1,3, Cynthia Formosa2
Authors Information

1: Department of Health, Malta

2: Faculty of Health Sciences, University of Malta

3: Faculty of Medicine and Surgery, University of Malta
Keywords: Rheumatoid arthritis, ankle brachial pressure index, cardiovascular disease risk factors, screening
References
  1. Scott D L, Wolfe F, Huizinga T W J. Rheumatoid arthritis. Lancet 2010;376(9746):1094-108.
  2. Edmonds M, Wall B. Metabolic disorders. In: Lorimer D, French G, O’Donnel M, Burrow J, editors. Naele’s Disorders of the Foot. 6th ed. New York: Churchill Livingstone; 2002.
  3. DeMaria A N. Relative risk of cardiovascular events in patients with rheumatoid arthritis. Am J Cardiol 2002;89:33D-38D.
  4. González-Gay M A, González-Juanatey C. Inflammation and lipid profile in rheumatoid arthritis: bridging an apparent paradox. Ann Rheum Dis 2014;731281-3.
  5. Galkina E, Ley K. Immune and inflammatory mechanisms of atherosclerosis. Annu Rev Immunol  2009;27:165-97.
  6. Chuang Y W, Yu M C, Lin C L, Yu T M, Shu K H, Huang S T, et al. Risk of peripheral arterial occlusive disease in patients with rheumatoid arthritis. A nationwide population-based cohort study. Thromb Haemost 2016;115:439-45.
  7. Orchard T, Strandness D. Assessment of Peripheral Vascular Disease in Diabetes: Report and Recommendations of an International Workshop Sponsored by the American Heart Association and the American Diabetes Association. Diabetes Care 1993;16:1199-209.
  8. McIntosh C. Assessing the vascular status of the feet in patients with diabetes. Wounds Essent. 2006;1:143-7.
  9. Horowitz E, Rehm K. PVD and DPM: Should Podiatrists Be the Referrer or the Referee? Pod Manag 2011;(April/May).
  10. Fraidoon A, Merza R, Mohammad K, Amin O, Abdullah R. Rheumatoid Arthritis and the Ankle-Brachial Pressure Index: Any Association? Cukurova Med J 2014; 39:83-90.
  11. Stamatelopoulos K S, Kitas G D, Papamichael C M, Kyrkou K, Zampeli E, Fragiadaki K, et al. Subclinical peripheral arterial disease in rheumatoid arthritis. Atherosclerosis 2010;212:305-9.
  12. Lindhardsen J, Ahlehoff O, Gislason G H, Madsen O R, Olesen J B, Torp-Pedersen C, et al. The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study. Ann Rheum Dis 2011;70:929-34.
  13. Fowkes F G R, Murray G D, Butcher I, Heald C L, Lee R J, Chambless L E, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008;300:197-208.
  14. Criqui MH, McClelland RL, McDermott MM, Allison MA, Blumenthal RS, Aboyans V, et al. The ankle-brachial index and incident cardiovascular events in the MESA (Multi-Ethnic study of atherosclerosis). J Am Coll Cardiol 2010;56:1506-12.
  15. Kurt T, Temiz A, Gokmen F, Adam G, Ozcan S, Ozbudak E, et al. Can the ankle brachial pressure index (ABPI) and carotis intima media thickness (CIMT) be new early stage markers of subclinical atherosclerosis in patients with rheumatoid arthritis? Wien Klin Wochenschr 2010;127:529-34.
  16. Aletaha D, Neogi T, Silman A, Funovits J, Felson D, Bingham C. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010;69:1580-8.
  17. Pham H, Armstrong D, Harvey C, Harkless L, Giurini J, Veves A. Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. Diabetes Care 2000;23:606-11.
  18. Formosa C, Cassar K, Gatt A, Mizzi A, Mizzi S, Camileri K P, et al. Hidden dangers revealed by misdiagnosed peripheral arterial disease using ABPI measurement. Diabetes Res Clin Pract 2013;102:112-6.
  19. Gorman P, De Nunzzio M, Donnelly R. Methods of arterial and venous assessment. In: ABC of arterial and venous disease. 2nd ed. London: Blackwell Publishing Limited; 2009. p. 128.
  20. American Diabetes Association. Standards of Medical Care in Diabetes-2015. Diabetes Care  2015;38:1-94.
  21. van Halm V P, Peters M J L, Voskuyl a E, Boers M, Lems W F, Visser M, et al. Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation. Ann Rheum Dis 2009;68:1395-400.
  22. Grisar J, Aletaha D, Steiner C W, Kapral T, Steiner S, Seidinger D, et al. Depletion of Endothelial Progenitor Cells in the Peripheral Blood of Patients With Rheumatoid Arthritis. Circulation 2005; 111.
  23. Wolfe F, Michaud K. Effect of body mass index on mortality and clinical status in rheumatoid arthritis. Arthritis Care Res 2012;64:1471-9.
  24. Sattar N, McCarey D W, Capell H, McInnes I B. Explaining How High-Grade Systemic Inflammation Accelerates Vascular Risk in Rheumatoid Arthritis. Circulation. 2003;108:2957-63. 
  25. Low A S, Symmons D P, Lunt M, Mercer L K, Gale C P, Watson K D, et al., British Society for Rheumatology Biologics Register for Rheumatoid Arthritis (BSRBR-RA) and the BSRBR Control Centre Consortium. Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis. Ann Rheum Dis 2016;76:654-60.
  26. Myasoedova E, Gabriel S E, Matteson E L, Davis J M 3rd, Therneau T M, Crowson C S. Decreased Cardiovascular Mortality in Patients with Incident Rheumatoid Arthritis (RA) in Recent Years: Dawn of a New Era in Cardiovascular Disease in RA? J Rheumatol 2017;44:732-39.